nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—PGR—breast cancer	0.185	0.613	CbGaD
Norgestimate—ESR1—breast cancer	0.117	0.387	CbGaD
Norgestimate—ESR1—Toremifene—breast cancer	0.0769	0.205	CbGbCtD
Norgestimate—ESR1—Fluoxymesterone—breast cancer	0.0769	0.205	CbGbCtD
Norgestimate—ESR1—Fulvestrant—breast cancer	0.0715	0.191	CbGbCtD
Norgestimate—Testosterone—Exemestane—breast cancer	0.0554	0.236	CrCrCtD
Norgestimate—Norethindrone—Fluoxymesterone—breast cancer	0.0525	0.224	CrCrCtD
Norgestimate—Progesterone—Fluoxymesterone—breast cancer	0.0442	0.188	CrCrCtD
Norgestimate—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0442	0.188	CrCrCtD
Norgestimate—ESR1—Raloxifene—breast cancer	0.0425	0.113	CbGbCtD
Norgestimate—Testosterone—Fluoxymesterone—breast cancer	0.0384	0.164	CrCrCtD
Norgestimate—ESR1—Tamoxifen—breast cancer	0.0281	0.0749	CbGbCtD
Norgestimate—ABCC2—Tamoxifen—breast cancer	0.0148	0.0394	CbGbCtD
Norgestimate—ABCC2—Paclitaxel—breast cancer	0.0115	0.0307	CbGbCtD
Norgestimate—ABCC2—Irinotecan—breast cancer	0.0113	0.0303	CbGbCtD
Norgestimate—ABCC2—Carboplatin—breast cancer	0.0108	0.0289	CbGbCtD
Norgestimate—ABCC2—Vinblastine—breast cancer	0.0101	0.0269	CbGbCtD
Norgestimate—ABCC2—Docetaxel—breast cancer	0.00831	0.0222	CbGbCtD
Norgestimate—PGR—corpus luteum—breast cancer	0.00824	0.353	CbGeAlD
Norgestimate—ABCC2—Doxorubicin—breast cancer	0.0062	0.0165	CbGbCtD
Norgestimate—ABCC2—Methotrexate—breast cancer	0.006	0.016	CbGbCtD
Norgestimate—PGR—mammary gland—breast cancer	0.00128	0.0546	CbGeAlD
Norgestimate—PGR—nipple—breast cancer	0.00106	0.0452	CbGeAlD
Norgestimate—ESR1—mammary gland—breast cancer	0.000999	0.0427	CbGeAlD
Norgestimate—PGR—epithelium—breast cancer	0.000711	0.0304	CbGeAlD
Norgestimate—ESR1—embryo—breast cancer	0.000682	0.0292	CbGeAlD
Norgestimate—PGR—endometrium—breast cancer	0.000638	0.0273	CbGeAlD
Norgestimate—PGR—uterus—breast cancer	0.000588	0.0251	CbGeAlD
Norgestimate—PGR—pituitary gland—breast cancer	0.000577	0.0247	CbGeAlD
Norgestimate—PGR—adipose tissue—breast cancer	0.000575	0.0246	CbGeAlD
Norgestimate—ESR1—epithelium—breast cancer	0.000556	0.0238	CbGeAlD
Norgestimate—PGR—female reproductive system—breast cancer	0.000528	0.0226	CbGeAlD
Norgestimate—PGR—adrenal gland—breast cancer	0.000516	0.0221	CbGeAlD
Norgestimate—ESR1—endometrium—breast cancer	0.000499	0.0213	CbGeAlD
Norgestimate—PGR—female gonad—breast cancer	0.000481	0.0206	CbGeAlD
Norgestimate—ESR1—uterus—breast cancer	0.00046	0.0197	CbGeAlD
Norgestimate—ABCC2—female reproductive system—breast cancer	0.000454	0.0194	CbGeAlD
Norgestimate—ESR1—pituitary gland—breast cancer	0.000451	0.0193	CbGeAlD
Norgestimate—ESR1—adipose tissue—breast cancer	0.00045	0.0192	CbGeAlD
Norgestimate—PGR—endocrine gland—breast cancer	0.000447	0.0191	CbGeAlD
Norgestimate—ABCC2—adrenal gland—breast cancer	0.000443	0.0189	CbGeAlD
Norgestimate—ESR1—female reproductive system—breast cancer	0.000413	0.0177	CbGeAlD
Norgestimate—ESR1—adrenal gland—breast cancer	0.000403	0.0173	CbGeAlD
Norgestimate—ABCC2—endocrine gland—breast cancer	0.000384	0.0164	CbGeAlD
Norgestimate—ESR1—female gonad—breast cancer	0.000376	0.0161	CbGeAlD
Norgestimate—ESR1—endocrine gland—breast cancer	0.00035	0.015	CbGeAlD
Norgestimate—PGR—lymph node—breast cancer	0.000309	0.0132	CbGeAlD
Norgestimate—ABCC2—lymph node—breast cancer	0.000265	0.0114	CbGeAlD
Norgestimate—ESR1—lymph node—breast cancer	0.000242	0.0103	CbGeAlD
Norgestimate—Ethynodiol—PGR—breast cancer	0.000174	0.0497	CrCbGaD
Norgestimate—Allylestrenol—PGR—breast cancer	0.000164	0.0469	CrCbGaD
Norgestimate—Norelgestromin—PGR—breast cancer	0.000164	0.0469	CrCbGaD
Norgestimate—Desogestrel—PGR—breast cancer	0.000158	0.0451	CrCbGaD
Norgestimate—Desogestrel—SHBG—breast cancer	0.000148	0.0422	CrCbGaD
Norgestimate—Nandrolone phenpropionate—AR—breast cancer	0.000147	0.042	CrCbGaD
Norgestimate—Etonogestrel—PGR—breast cancer	0.000128	0.0365	CrCbGaD
Norgestimate—Testosterone Propionate—CYP17A1—breast cancer	0.000125	0.0358	CrCbGaD
Norgestimate—Nandrolone phenpropionate—CYP19A1—breast cancer	0.000123	0.0352	CrCbGaD
Norgestimate—Etonogestrel—SHBG—breast cancer	0.000119	0.0341	CrCbGaD
Norgestimate—Nandrolone decanoate—AR—breast cancer	0.000111	0.0318	CrCbGaD
Norgestimate—Ethynodiol—ESR1—breast cancer	0.00011	0.0313	CrCbGaD
Norgestimate—Allylestrenol—ESR1—breast cancer	0.000104	0.0296	CrCbGaD
Norgestimate—Testosterone Propionate—COMT—breast cancer	0.000102	0.0292	CrCbGaD
Norgestimate—Desogestrel—ESR1—breast cancer	9.96e-05	0.0285	CrCbGaD
Norgestimate—Nandrolone decanoate—CYP19A1—breast cancer	9.32e-05	0.0267	CrCbGaD
Norgestimate—Levonorgestrel—PGR—breast cancer	9.04e-05	0.0258	CrCbGaD
Norgestimate—Levonorgestrel—SHBG—breast cancer	8.45e-05	0.0242	CrCbGaD
Norgestimate—Etonogestrel—ESR1—breast cancer	8.06e-05	0.0231	CrCbGaD
Norgestimate—Testosterone Propionate—AR—breast cancer	7.62e-05	0.0218	CrCbGaD
Norgestimate—Levonorgestrel—AR—breast cancer	7.41e-05	0.0212	CrCbGaD
Norgestimate—Norethindrone—PGR—breast cancer	7.32e-05	0.0209	CrCbGaD
Norgestimate—Norethindrone—SHBG—breast cancer	6.84e-05	0.0196	CrCbGaD
Norgestimate—Levonorgestrel—CYP19A1—breast cancer	6.2e-05	0.0177	CrCbGaD
Norgestimate—Progesterone—CYP17A1—breast cancer	5.75e-05	0.0165	CrCbGaD
Norgestimate—Levonorgestrel—ESR1—breast cancer	5.71e-05	0.0163	CrCbGaD
Norgestimate—Allylestrenol—CYP3A4—breast cancer	5.28e-05	0.0151	CrCbGaD
Norgestimate—Progesterone—ABCC1—breast cancer	5.22e-05	0.0149	CrCbGaD
Norgestimate—Progesterone—PGR—breast cancer	4.27e-05	0.0122	CrCbGaD
Norgestimate—Etonogestrel—CYP3A4—breast cancer	4.12e-05	0.0118	CrCbGaD
Norgestimate—Progesterone—SHBG—breast cancer	3.99e-05	0.0114	CrCbGaD
Norgestimate—Progesterone—CYP1B1—breast cancer	3.99e-05	0.0114	CrCbGaD
Norgestimate—Testosterone—SHBG—breast cancer	3.77e-05	0.0108	CrCbGaD
Norgestimate—Testosterone—CYP1B1—breast cancer	3.77e-05	0.0108	CrCbGaD
Norgestimate—Progesterone—AR—breast cancer	3.5e-05	0.01	CrCbGaD
Norgestimate—Testosterone—AR—breast cancer	3.31e-05	0.00946	CrCbGaD
Norgestimate—Levonorgestrel—CYP3A4—breast cancer	2.91e-05	0.00833	CrCbGaD
Norgestimate—Testosterone—CYP19A1—breast cancer	2.77e-05	0.00792	CrCbGaD
Norgestimate—Progesterone—ESR1—breast cancer	2.69e-05	0.00771	CrCbGaD
Norgestimate—Testosterone—ABCG2—breast cancer	2.6e-05	0.00744	CrCbGaD
Norgestimate—Norethindrone—CYP3A4—breast cancer	2.36e-05	0.00675	CrCbGaD
Norgestimate—Progesterone—CYP1A1—breast cancer	2.15e-05	0.00616	CrCbGaD
Norgestimate—Norethindrone—ALB—breast cancer	2.06e-05	0.00589	CrCbGaD
Norgestimate—Testosterone—CYP1A1—breast cancer	2.04e-05	0.00582	CrCbGaD
Norgestimate—Norethindrone—ABCB1—breast cancer	1.96e-05	0.00562	CrCbGaD
Norgestimate—Progesterone—CYP2D6—breast cancer	1.6e-05	0.00458	CrCbGaD
Norgestimate—Progesterone—CYP3A4—breast cancer	1.37e-05	0.00393	CrCbGaD
Norgestimate—Testosterone—CYP3A4—breast cancer	1.3e-05	0.00372	CrCbGaD
Norgestimate—Progesterone—ABCB1—breast cancer	1.14e-05	0.00327	CrCbGaD
Norgestimate—Testosterone—ALB—breast cancer	1.13e-05	0.00324	CrCbGaD
Norgestimate—Testosterone—ABCB1—breast cancer	1.08e-05	0.00309	CrCbGaD
Norgestimate—ESR1—Signaling Pathways—VCP—breast cancer	1e-05	0.000161	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FLT1—breast cancer	1e-05	0.000161	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—IL6—breast cancer	9.97e-06	0.00016	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGF3—breast cancer	9.97e-06	0.00016	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SQSTM1—breast cancer	9.97e-06	0.00016	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—HSPA1B—breast cancer	9.92e-06	0.00016	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—LEPR—breast cancer	9.85e-06	0.000158	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—JAG1—breast cancer	9.84e-06	0.000158	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PARP1—breast cancer	9.8e-06	0.000158	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NOTCH3—breast cancer	9.8e-06	0.000158	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CALCA—breast cancer	9.68e-06	0.000156	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—RPS6—breast cancer	9.56e-06	0.000154	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PGR—breast cancer	9.51e-06	0.000153	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGF4—breast cancer	9.49e-06	0.000153	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCR4—breast cancer	9.45e-06	0.000152	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCL12—breast cancer	9.45e-06	0.000152	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.38e-06	0.000151	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—MYC—breast cancer	9.35e-06	0.00015	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—DNMT1—breast cancer	9.33e-06	0.00015	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PAK1—breast cancer	9.28e-06	0.000149	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—AKT1—breast cancer	9.25e-06	0.000149	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—AKT1—breast cancer	9.2e-06	0.000148	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NCOA2—breast cancer	9.16e-06	0.000147	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ARHGDIA—breast cancer	9.16e-06	0.000147	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TCF7L2—breast cancer	9.12e-06	0.000147	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	9.07e-06	0.000146	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—EZH2—breast cancer	9.04e-06	0.000145	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FST—breast cancer	8.92e-06	0.000144	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NOTCH3—breast cancer	8.85e-06	0.000142	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PARP1—breast cancer	8.85e-06	0.000142	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HEY2—breast cancer	8.82e-06	0.000142	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HSP90AA1—breast cancer	8.79e-06	0.000141	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NOTCH2—breast cancer	8.79e-06	0.000141	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RPS6KB2—breast cancer	8.71e-06	0.00014	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—SERPINE1—breast cancer	8.67e-06	0.00014	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—ESR1—breast cancer	8.66e-06	0.000139	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—RPS6—breast cancer	8.63e-06	0.000139	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RGS2—breast cancer	8.61e-06	0.000139	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PRL—breast cancer	8.55e-06	0.000138	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AGTR1—breast cancer	8.55e-06	0.000138	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCL20—breast cancer	8.51e-06	0.000137	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ADAM10—breast cancer	8.43e-06	0.000136	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STK11—breast cancer	8.43e-06	0.000136	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—ESR2—breast cancer	8.38e-06	0.000135	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—NOTCH1—breast cancer	8.37e-06	0.000135	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PLG—breast cancer	8.33e-06	0.000134	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—LPAR1—breast cancer	8.25e-06	0.000133	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TLE3—breast cancer	8.25e-06	0.000133	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGF10—breast cancer	8.2e-06	0.000132	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HEY1—breast cancer	8.16e-06	0.000131	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—DLL1—breast cancer	8e-06	0.000129	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NOTCH2—breast cancer	7.93e-06	0.000128	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PDGFA—breast cancer	7.91e-06	0.000127	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HIST1H2BK—breast cancer	7.86e-06	0.000126	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HIST1H2BC—breast cancer	7.86e-06	0.000126	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TGFBR2—breast cancer	7.8e-06	0.000125	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PDE4D—breast cancer	7.79e-06	0.000125	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—GRB7—breast cancer	7.79e-06	0.000125	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	7.79e-06	0.000125	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NCOA1—breast cancer	7.72e-06	0.000124	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ITPR1—breast cancer	7.67e-06	0.000123	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.66e-06	0.000123	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TAB2—breast cancer	7.65e-06	0.000123	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MMP3—breast cancer	7.62e-06	0.000123	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ERBB4—breast cancer	7.62e-06	0.000123	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STAT5A—breast cancer	7.62e-06	0.000123	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CNR2—breast cancer	7.59e-06	0.000122	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—DKK1—breast cancer	7.41e-06	0.000119	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—AR—breast cancer	7.4e-06	0.000119	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SMAD4—breast cancer	7.38e-06	0.000119	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFC—breast cancer	7.35e-06	0.000118	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IGF1R—breast cancer	7.34e-06	0.000118	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—JAG2—breast cancer	7.24e-06	0.000116	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HES1—breast cancer	7.21e-06	0.000116	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PLA2G4A—breast cancer	7.16e-06	0.000115	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NCOR1—breast cancer	7.16e-06	0.000115	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—WNT1—breast cancer	7.13e-06	0.000115	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—SERPINE1—breast cancer	7.11e-06	0.000114	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGF1—breast cancer	7.08e-06	0.000114	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CSF2—breast cancer	7.08e-06	0.000114	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	7.04e-06	0.000113	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NRG1—breast cancer	7.03e-06	0.000113	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—H2AFX—breast cancer	6.98e-06	0.000112	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—E2F1—breast cancer	6.93e-06	0.000112	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOTCH4—breast cancer	6.76e-06	0.000109	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—SIRT1—breast cancer	6.75e-06	0.000109	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—GZMB—breast cancer	6.72e-06	0.000108	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—SMAD4—breast cancer	6.66e-06	0.000107	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SPP1—breast cancer	6.66e-06	0.000107	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—VDR—breast cancer	6.65e-06	0.000107	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ERBB3—breast cancer	6.59e-06	0.000106	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGFR2—breast cancer	6.58e-06	0.000106	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL2—breast cancer	6.53e-06	0.000105	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AGTR2—breast cancer	6.53e-06	0.000105	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NCOR1—breast cancer	6.47e-06	0.000104	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PTHLH—breast cancer	6.45e-06	0.000104	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—BMP2—breast cancer	6.45e-06	0.000104	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TERT—breast cancer	6.31e-06	0.000102	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—H2AFX—breast cancer	6.3e-06	0.000101	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EDNRB—breast cancer	6.25e-06	0.000101	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PGR—breast cancer	6.19e-06	9.95e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—THBS1—breast cancer	6.16e-06	9.9e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGFR1—breast cancer	6.13e-06	9.86e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—ERCC2—breast cancer	6.08e-06	9.78e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HIF1A—breast cancer	6.04e-06	9.72e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—LEP—breast cancer	5.89e-06	9.48e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FLT1—breast cancer	5.88e-06	9.45e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGF3—breast cancer	5.85e-06	9.41e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SQSTM1—breast cancer	5.85e-06	9.41e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CAV1—breast cancer	5.84e-06	9.4e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—JAG1—breast cancer	5.78e-06	9.29e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KDR—breast cancer	5.78e-06	9.29e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PARP1—breast cancer	5.75e-06	9.25e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOTCH3—breast cancer	5.75e-06	9.25e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CALCA—breast cancer	5.68e-06	9.14e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ESR1—breast cancer	5.63e-06	9.05e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RPS6—breast cancer	5.61e-06	9.03e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGF4—breast cancer	5.57e-06	8.96e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FN1—breast cancer	5.56e-06	8.94e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCR4—breast cancer	5.55e-06	8.93e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL12—breast cancer	5.55e-06	8.93e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NFKBIA—breast cancer	5.49e-06	8.84e-05	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—MYC—breast cancer	5.49e-06	8.83e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PAK1—breast cancer	5.45e-06	8.76e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NOTCH1—breast cancer	5.44e-06	8.75e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TCF7L2—breast cancer	5.35e-06	8.61e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—APC—breast cancer	5.32e-06	8.56e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KIT—breast cancer	5.32e-06	8.56e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CG—breast cancer	5.32e-06	8.56e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EGF—breast cancer	5.26e-06	8.46e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOTCH2—breast cancer	5.16e-06	8.3e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HSP90AA1—breast cancer	5.16e-06	8.3e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PRL—breast cancer	5.02e-06	8.07e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AGTR1—breast cancer	5.02e-06	8.07e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—BRAF—breast cancer	5e-06	8.05e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STK11—breast cancer	4.95e-06	7.96e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ADAM10—breast cancer	4.95e-06	7.96e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NOTCH1—breast cancer	4.91e-06	7.9e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PLG—breast cancer	4.89e-06	7.87e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IGF1—breast cancer	4.87e-06	7.84e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKT2—breast cancer	4.87e-06	7.83e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGF10—breast cancer	4.81e-06	7.74e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CD—breast cancer	4.68e-06	7.52e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PDGFA—breast cancer	4.64e-06	7.47e-05	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—MAPK3—breast cancer	4.63e-06	7.45e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SERPINE1—breast cancer	4.63e-06	7.44e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TGFBR2—breast cancer	4.58e-06	7.36e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ITPR1—breast cancer	4.5e-06	7.24e-05	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—MYC—breast cancer	4.5e-06	7.24e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ERBB4—breast cancer	4.47e-06	7.2e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MMP3—breast cancer	4.47e-06	7.2e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STAT5A—breast cancer	4.47e-06	7.2e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NOS3—breast cancer	4.42e-06	7.11e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SMAD4—breast cancer	4.33e-06	6.97e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IGF1R—breast cancer	4.31e-06	6.93e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HES1—breast cancer	4.23e-06	6.8e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PLA2G4A—breast cancer	4.2e-06	6.77e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NCOR1—breast cancer	4.2e-06	6.77e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MDM2—breast cancer	4.19e-06	6.74e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—SERPINE1—breast cancer	4.18e-06	6.72e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—RAF1—breast cancer	4.18e-06	6.72e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CSF2—breast cancer	4.16e-06	6.69e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGF1—breast cancer	4.16e-06	6.69e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—RELA—breast cancer	4.16e-06	6.69e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ERBB2—breast cancer	4.13e-06	6.65e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NRG1—breast cancer	4.13e-06	6.64e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—H2AFX—breast cancer	4.1e-06	6.59e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MTOR—breast cancer	4.08e-06	6.56e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CB—breast cancer	4.08e-06	6.56e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—E2F1—breast cancer	4.07e-06	6.55e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCL8—breast cancer	3.92e-06	6.3e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SPP1—breast cancer	3.91e-06	6.29e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ERBB3—breast cancer	3.87e-06	6.22e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGFR2—breast cancer	3.86e-06	6.21e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN1B—breast cancer	3.83e-06	6.15e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CASP3—breast cancer	3.75e-06	6.03e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL2—breast cancer	3.74e-06	6.02e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TERT—breast cancer	3.71e-06	5.96e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CCND1—breast cancer	3.65e-06	5.87e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—JUN—breast cancer	3.64e-06	5.86e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CTNNB1—breast cancer	3.61e-06	5.81e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGFR1—breast cancer	3.6e-06	5.79e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HIF1A—breast cancer	3.54e-06	5.7e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MMP9—breast cancer	3.54e-06	5.7e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN1A—breast cancer	3.53e-06	5.68e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PTEN—breast cancer	3.52e-06	5.67e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—LEP—breast cancer	3.46e-06	5.57e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MAPK8—breast cancer	3.45e-06	5.54e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CAV1—breast cancer	3.43e-06	5.52e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KDR—breast cancer	3.39e-06	5.45e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SRC—breast cancer	3.27e-06	5.26e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FN1—breast cancer	3.26e-06	5.25e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NFKBIA—breast cancer	3.22e-06	5.19e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOTCH1—breast cancer	3.19e-06	5.14e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—breast cancer	3.18e-06	5.12e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STAT3—breast cancer	3.15e-06	5.07e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CG—breast cancer	3.12e-06	5.02e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KIT—breast cancer	3.12e-06	5.02e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—APC—breast cancer	3.12e-06	5.02e-05	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—AKT1—breast cancer	3.12e-06	5.02e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EGF—breast cancer	3.09e-06	4.97e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MAPK3—breast cancer	3.01e-06	4.84e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—BRAF—breast cancer	2.93e-06	4.72e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MYC—breast cancer	2.93e-06	4.71e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TGFB1—breast cancer	2.92e-06	4.7e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EGFR—breast cancer	2.86e-06	4.61e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IGF1—breast cancer	2.86e-06	4.6e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKT2—breast cancer	2.86e-06	4.6e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CD—breast cancer	2.74e-06	4.42e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—MAPK3—breast cancer	2.72e-06	4.37e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SERPINE1—breast cancer	2.71e-06	4.37e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KRAS—breast cancer	2.7e-06	4.35e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—MYC—breast cancer	2.64e-06	4.25e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOS3—breast cancer	2.59e-06	4.17e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CA—breast cancer	2.49e-06	4e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MDM2—breast cancer	2.46e-06	3.96e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RAF1—breast cancer	2.45e-06	3.94e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RELA—breast cancer	2.44e-06	3.93e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ERBB2—breast cancer	2.42e-06	3.9e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—breast cancer	2.4e-06	3.87e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CB—breast cancer	2.39e-06	3.85e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MTOR—breast cancer	2.39e-06	3.85e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL8—breast cancer	2.3e-06	3.7e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HRAS—breast cancer	2.3e-06	3.7e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN1B—breast cancer	2.25e-06	3.61e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CASP3—breast cancer	2.2e-06	3.54e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IL6—breast cancer	2.2e-06	3.54e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL2—breast cancer	2.2e-06	3.54e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCND1—breast cancer	2.14e-06	3.45e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—JUN—breast cancer	2.14e-06	3.44e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CTNNB1—breast cancer	2.12e-06	3.41e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MMP9—breast cancer	2.08e-06	3.35e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN1A—breast cancer	2.07e-06	3.33e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PTEN—breast cancer	2.07e-06	3.33e-05	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKT1—breast cancer	2.03e-06	3.27e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MAPK8—breast cancer	2.02e-06	3.25e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SRC—breast cancer	1.92e-06	3.08e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—breast cancer	1.87e-06	3e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STAT3—breast cancer	1.85e-06	2.97e-05	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—AKT1—breast cancer	1.83e-06	2.95e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MAPK3—breast cancer	1.77e-06	2.84e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MYC—breast cancer	1.72e-06	2.76e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TGFB1—breast cancer	1.71e-06	2.76e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EGFR—breast cancer	1.68e-06	2.7e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KRAS—breast cancer	1.59e-06	2.55e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CA—breast cancer	1.46e-06	2.35e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—breast cancer	1.41e-06	2.27e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HRAS—breast cancer	1.35e-06	2.17e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IL6—breast cancer	1.29e-06	2.08e-05	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKT1—breast cancer	1.19e-06	1.92e-05	CbGpPWpGaD
